Association of vitronectin and plasminogen activator inhibitor-1 levels with the risk of metabolic syndrome and type 2 diabetes mellitus. Results from the D.E.S.I.R. prospective cohort - Alessi, M C; Nicaud, V; Scroyen, IDESIR Study Group (Thromb Haemost, 2011)
, et al;